| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |